eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 31/10/2011
PIL Sevoflurane

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
Updated on 27/01/2011 and displayed until 31/10/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to side-effects
Updated on 21/01/2010 and displayed until 27/01/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 12/10/2009 and displayed until 21/01/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/06/2009 and displayed until 12/10/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 07/01/2009 and displayed until 24/06/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 03/12/2008 and displayed until 07/01/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 24/09/2008 and displayed until 03/12/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 14/05/2008 and displayed until 24/09/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 19/03/2007 and displayed until 14/05/2008
Reasons for adding or updating:
  • Change to date of revision
  • Improved Electronic Presentation
Updated on 02/03/2007 and displayed until 19/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 07/11/2006 and displayed until 02/03/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/11/2005 and displayed until 07/11/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change of inactive ingredient
Updated on 24/09/2004 and displayed until 02/11/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/07/2003 and displayed until 24/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 16/07/2001 and displayed until 08/07/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 07/08/2000 and displayed until 16/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sevoflurane